{
    "2020-11-12": [
        [
            {
                "time": "",
                "original_text": "【权益变动】泰格医药(03347-HK)获SandsCapitalManagement,LLC增持37.54万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "SandsCapitalManagement",
                        "增持",
                        "37.54万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业11月月报暨三季报总结：三季报医药整体表现良好 当前时点重点关注Q3业绩超预期的疫苗、CXO、医疗服务、零售药店等板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "业绩超预期",
                        "疫苗",
                        "CXO",
                        "医疗服务",
                        "零售药店"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}